It is hypothesised that the association between SHBG and MetS is mediated by the inhibitory effect of insulin on the synthesis of SHBG.65 The association of sex hormone levels with CMD risk factors during menopause indicates that hormone therapy may be a useful intervention strategy for these diseases. The gene discussed is PLXNA3; the disease is metabolic syndrome.